NSC |
Compound |
Enrichment |
Correlation |
NSC 3060 |
Arsenenous acid, potassium salt (9CI) |
0.00160168059169488 |
0.38775625 |
NSC 633398 |
Null |
0.00160168059169488 |
0.30792481 |
NSC 678049 |
Null |
0.0016016805916949 |
0.34203675 |
NSC 702015 |
1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- |
0.0016016805916949 |
0.32280915 |
NSC 703174 |
Null |
0.0016016805916949 |
0.55494568 |
NSC 710266 |
Null |
0.0016016805916949 |
0.4864303 |
NSC 741412 |
4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one |
0.0016016805916949 |
0.47686961 |
NSC 658145 |
2-(2-(Dimethylamino)ethylamino)naphthazarin |
0.00166561193816139 |
0.72518862 |
NSC 680410 |
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester (9CI) |
0.00166561193816139 |
0.28550687 |
NSC 681684 |
2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol |
0.00166561193816139 |
0.62217444 |